If you need more lookups,
subscriptions start at $34 USD/month.
Kat V. Work
Market Access Lead (GR and CY) @ (January 2026 - Present)
External Consultant @ (April 2024 - October 2024)
Public Affairs Manager, Global Rare Disease @ (July 2023 - March 2024)
Market Access and Public Affairs Manager @ (July 2021 - August 2023)
Market Access Manager, Greece and Cyprus @ (September 2018 - May 2022)
Consultant HealthCare and Pharma @ Freelance Consultant (March 2018 - December 2018)
Sabbatical Year @ Life beyond Profession (March 2017 - February 2018)
Market Access Manager, Government Affairs Dept @ (February 2014 - March 2017)
Pricing and Access Executive @ Eli Lilly and Company (March 2013 - January 2014)
Head of Pricing and Regulatory Affairs Dept @ Eli Lilly and Company (September 2010 - March 2013)
Head of Regulatory affairs @ Eli Lilly and Company (September 2006 - September 2010)
Product Specialist Oncology Group @ Eli Lilly and Company (November 2005 - September 2006)
Sales Representative CNS group @ Eli Lilly and Company (January 2004 - November 2005)
Kat V. Education
Imperial College London
MSc (Molecular Medicine)
2003
University of Patras
Chemistry
2002
Arsakeio-Tositseio School 1997
University of Piraeus
Msc in Health Economics & Management
2017
Kat V. Summary
Kat V., is currently a Market Access Lead (GR and CY) at Novo Nordisk. Kat V. brings experience from previous roles at Rethink Culture and Novo Nordisk. Kat V. holds a MSc in Molecular Medicine @ Imperial College London. Kat V. has 2 emails on RocketReach.
Looking for a different Kat V.?
Find contact details for 700 million professionals.